» Articles » PMID: 33279819

COVID-19 in Brazil: 150,000 Deaths and the Brazilian Underreporting

Overview
Date 2020 Dec 6
PMID 33279819
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Brazil is one of the epicenters of the COVID-19 pandemic and has reported 5,113,628 cases and 150,998 deaths by the disease. Comparing the deaths by natural causes expected and the excess mortality rate, there is a 22% increase in deaths mainly of male patients and individuals over 60 years old.

Citing Articles

[Overall excess mortality and COVID-19 mortality in Brazil and Brazilian regions in 2020].

Macedo L, Araujo C, Carvalho L, Lobato J, Paiva N, Costa A Cad Saude Publica. 2025; 40(11):e00217323.

PMID: 39813565 PMC: 11729369. DOI: 10.1590/0102-311XPT217323.


Efficacy of Ivermectin, Chloroquine/Hydroxychloroquine, and Azithromycin in Managing COVID-19: A Systematic Review of Phase III Clinical Trials.

Sansone N, Boschiero M, Marson F Biomedicines. 2024; 12(10).

PMID: 39457519 PMC: 11505156. DOI: 10.3390/biomedicines12102206.


Point-of-care testing for COVID-19: a simple two-step molecular diagnostic development and validation during the SARS-CoV-2 pandemic.

Yoshikawa A, Cardoso S, Eslabao L, Pinheiro I, Valverde P, Caminha G Mem Inst Oswaldo Cruz. 2024; 119:e230236.

PMID: 39383402 PMC: 11452069. DOI: 10.1590/0074-02760230236.


Wastewater surveillance for viral pathogens: A tool for public health.

Carmo Dos Santos M, Cerqueira Silva A, Dos Reis Teixeira C, Pinheiro Macedo Prazeres F, Fernandes Dos Santos R, de Araujo Rolo C Heliyon. 2024; 10(13):e33873.

PMID: 39071684 PMC: 11279281. DOI: 10.1016/j.heliyon.2024.e33873.


Enhancing SARS-CoV-2 surveillance in Malawi using telephone syndromic surveillance from July 2020 to April 2022.

Woelk G, Maphosa T, Machekano R, Chauma-Mwale A, Makonokaya L, Zimba S BMJ Glob Health. 2024; 9(5).

PMID: 38754899 PMC: 11097830. DOI: 10.1136/bmjgh-2023-014941.


References
1.
The Lancet . COVID-19 in Brazil: "So what?". Lancet. 2020; 395(10235):1461. PMC: 7251993. DOI: 10.1016/S0140-6736(20)31095-3. View

2.
Palamim C, Marson F . COVID-19 - The Availability of ICU Beds in Brazil during the Onset of Pandemic. Ann Glob Health. 2020; 86(1):100. PMC: 7427679. DOI: 10.5334/aogh.3025. View

3.
Beigel J, Tomashek K, Dodd L, Mehta A, Zingman B, Kalil A . Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020; 383(19):1813-1826. PMC: 7262788. DOI: 10.1056/NEJMoa2007764. View

4.
Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

5.
Guaraldi G, Meschiari M, Cozzi-Lepri A, Milic J, Tonelli R, Menozzi M . Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020; 2(8):e474-e484. PMC: 7314456. DOI: 10.1016/S2665-9913(20)30173-9. View